<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Yawata M</submitter><funding>NIAID NIH HHS</funding><pagination>2369-80</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC2532809</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>112(6)</volume><pubmed_abstract>Variegated expression of 6 inhibitory HLA class I-specific receptors on primary NK cells was studied using high-dimension flow cytometry in 58 humans to understand the structure and function of NK-cell repertoires. Sixty-four subsets expressing all possible receptor com-binations were present in each repertoire, and the frequency of receptor-null cells varied among the donors. Enhancement in missing-self response between NK subsets varied substantially where subset responses were defined by donor KIR/HLA allotypes, reflecting the differences in interaction between inhibitory receptors and their ligands. This contrasted to the enhancement conferred by NKG2A, which was constant and of intermediate strength. We infer a mechanism that modulates frequencies of the NK subsets displaying diverse levels of missing-self response, a system that reduces the presence of KIR-expressing subsets that display either too strong or too weak a response and effectively replaces them with NKG2A-expressing cells in the repertoire. Through this high-resolution analysis of inhibitory receptor expression, 5 types of NK-cell repertoire were defined by their content of NKG2A(+)/NKG2A(-) cells, frequency of receptor-null cells, and degree of KIR receptor coexpression. The analyses provide new perspective on how personalized human NK-cell repertoires are structured.</pubmed_abstract><journal>Blood</journal><pubmed_title>MHC class I-specific inhibitory receptors and their ligands structure diverse human NK-cell repertoires toward a balance of missing self-response.</pubmed_title><pmcid>PMC2532809</pmcid><funding_grant_id>R01 AI022039</funding_grant_id><funding_grant_id>AI-31168</funding_grant_id><funding_grant_id>AI-22039</funding_grant_id><funding_grant_id>R01 AI031168</funding_grant_id><funding_grant_id>R01 AI017892</funding_grant_id><funding_grant_id>AI-17892</funding_grant_id><pubmed_authors>Partheniou F</pubmed_authors><pubmed_authors>Little AM</pubmed_authors><pubmed_authors>Parham P</pubmed_authors><pubmed_authors>Draghi M</pubmed_authors><pubmed_authors>Yawata M</pubmed_authors><pubmed_authors>Yawata N</pubmed_authors></additional><is_claimable>false</is_claimable><name>MHC class I-specific inhibitory receptors and their ligands structure diverse human NK-cell repertoires toward a balance of missing self-response.</name><description>Variegated expression of 6 inhibitory HLA class I-specific receptors on primary NK cells was studied using high-dimension flow cytometry in 58 humans to understand the structure and function of NK-cell repertoires. Sixty-four subsets expressing all possible receptor com-binations were present in each repertoire, and the frequency of receptor-null cells varied among the donors. Enhancement in missing-self response between NK subsets varied substantially where subset responses were defined by donor KIR/HLA allotypes, reflecting the differences in interaction between inhibitory receptors and their ligands. This contrasted to the enhancement conferred by NKG2A, which was constant and of intermediate strength. We infer a mechanism that modulates frequencies of the NK subsets displaying diverse levels of missing-self response, a system that reduces the presence of KIR-expressing subsets that display either too strong or too weak a response and effectively replaces them with NKG2A-expressing cells in the repertoire. Through this high-resolution analysis of inhibitory receptor expression, 5 types of NK-cell repertoire were defined by their content of NKG2A(+)/NKG2A(-) cells, frequency of receptor-null cells, and degree of KIR receptor coexpression. The analyses provide new perspective on how personalized human NK-cell repertoires are structured.</description><dates><release>2008-01-01T00:00:00Z</release><publication>2008 Sep</publication><modification>2026-03-16T16:22:16.61Z</modification><creation>2025-08-30T03:10:15.018Z</creation></dates><accession>S-EPMC2532809</accession><cross_references><pubmed>18583565</pubmed><doi>10.1182/blood-2008-03-143727</doi></cross_references></HashMap>